Jacqueline Nikpour

Jacqueline Nikpour

Auto-generated profile, based on publicly available information

Jacqueline Nikpour

Assistant Professor (Dr Nikpour), Assistant Research Professor (Bouvier), PhD Candidate (Razmpour), Nursing Informationist (Leslie), Associate Professor (Dr Cimiotti), Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA; Corporate Director of Nursing Science (Dr Bouvier), Emory Healthcare, Atlanta, GA; MBA Candidate (Razmpour), Goizueta Business School, Emory University, Atlanta, GA, Associate Professor, Rollins School of Public Health, Emory University, Atlanta, GA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2021 in Research in Nursing & Health
Verified
Journal Article
Open access
PDF file
LMLisa Mansfield
Lisa Mansfield
AVAshlee J. Vance
Ashlee J. Vance
JNJacqueline A. Nikpour
Jacqueline A. Nikpour
RGRosa M. Gonzalez‐Guarda
Rosa M. Gonzalez‐Guarda
The human papillomavirus (HPV) causes many anogenital and oral cancers affecting young adults in the United States. Vaccination during adolescence can prevent HPV‐associated cancers, but vaccine uptake among adolescents is low and influenced by factors serving as barriers and facilitators to HPV vaccination. In this systematic review, we synthesized research using the socioecological framework model to examine individual‐level, relationship‐level, community‐level, and societal‐level factors that influence HPV vaccine initiation and completion among US adolescents. The Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines were used to guide the methodology for this review. An electronic search was conducted in January 2020 using PubMed, Cumulative Index of Nursing and Allied Health Literature, ProQuest Central, Scopus, and American Psychological Association PsycInfo databases. The Joanna Briggs Institute tools were used to assess the quality for the 57 studies included in this review. The most consistent influences of HPV vaccination included age at vaccination, awareness, and knowledge about HPV vaccination, socioeconomic status, insurance status, race/ethnicity, and preventative care behaviors at the individual level. Provider recommendation, familial/peer support of vaccination, and parental health behaviors were influences at the relationship level. Although fewer findings elucidated community‐level and societal‐level influences, high‐poverty areas, high‐risk communities with large proportions of racial/ethnic minority groups, healthcare facilities servicing children, and combined health policies appear to serve as facilitators of HPV initiation and completion. Findings from this review can inform culturally relevant and age‐specific interventions and multi‐level policies aiming to improve HPV vaccination coverage in the United States.

20 April 2022 in Nursing Outlook
Verified
Journal Article
Open access
JNJacqueline Nikpour
Jacqueline Nikpour
RHRonald L. Hickman
Ronald L. Hickman
DCDora Clayton-Jones
Dora Clayton-Jones
RGRosa M. Gonzalez-Guarda
Rosa M. Gonzalez-Guarda
MBMarion E. Broome
Marion E. Broome
The purpose of this manuscript is to examine traditional models of leadership in nursing, and to provide a roadmap and specific recommendations for nurses at all levels to lead our profession through the next decade in achieving health equity. We examine current leadership frameworks in nursing and discuss ways to contemporize these frameworks to more explicitly center the expertise of clinicians and communities from historically marginalized backgrounds. Next, we examine the racial, gender, and able-bodied biases that impact nurses, and call upon nurses to examine and dismantle these biases. We discuss the roles of health systems and academic organizations in developing inclusive leaders, including through community engagement and true service-learning partnerships. Finally, we provide a set of recommendations for all nursing leaders across career stages to embrace inclusivity as they work to improve health equity.


12 September 2023 in Journal of the American Association of Nurse Practitioners
Verified
Journal Article
Closed access
JCJ. Margo Brooks Carthon
J. Margo Brooks Carthon
RARavenne Rn Aponte
Ravenne Rn Aponte
AMAleigha Rn Mason
Aleigha Rn Mason
JNJacqueline PhD Nikpour
Jacqueline PhD Nikpour
Background: Increasing diversity in the nurse practitioner (NP) workforce is key to improving outcomes among patients who experience health inequities. However, few studies to date have examined the specific mechanisms by which NPs from diverse backgrounds address inequities in care delivery. Purpose: To explore Black NPs' efforts in addressing inequities, and the facilitators and barriers they face in doing so. Methodology: We conducted focus groups and interviews of Black NPs (N = 16) in the greater Philadelphia area in early 2022, just following the height of the COVID-19 pandemic and the social unrest of the early 2020s. Data were analyzed using thematic analysis. Results: Emergent themes included: Strategies Utilized to Address Health Inequities; Burnout & the Minority Tax; Risks & Rewards of Taking a Stance; and Uneven Promises of Organizational Engagement. Nurse practitioners prioritized patient-centered, culturally congruent care, taking additional time to explore community resources and learn about patients' lives to facilitate care planning. Participants advocated to administrators for resources to address inequities while simultaneously navigating organizational dynamics, microaggressions, and racism. Finally, NPs identified organizational-level barriers, leading to emotional exhaustion and several participants' intent to leave their roles. Conclusions: Black NPs use a myriad of strategies to improve equity, yet frequently face substantial barriers and emotional exhaustion in doing so with little change to the inequities in care. Implications: The NP workforce has a critical role to play in reducing health inequities. The strategies outlined by Black NPs in this study offer a roadmap for all clinicians and health care organizations to prioritize equity in care delivery.

28 August 2022 in Journal of Hospital Medicine
Verified
Journal Article
Closed access
JTJacqueline N. Townley
Jacqueline N. Townley
CPColleen A. Pogue
Colleen A. Pogue
MMMatthew D. McHugh
Matthew D. McHugh

12 November 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
JCJ Margo Brooks Carthon
J Margo Brooks Carthon
HBHeather Brom
Heather Brom
KAKelvin Eyram Amenyedor
Kelvin Eyram Amenyedor
MHMichael O Harhay
Michael O Harhay
MGMarsha Grantham-Murillo
Marsha Grantham-Murillo
ABAmanda Bettencourt
Amanda Bettencourt
Background: People diagnosed with a co-occurring serious mental illness (SMI; ie, major depressive disorder, bipolar disorder, or schizophrenia) but hospitalized for a nonpsychiatric condition experience higher rates of readmissions and other adverse outcomes, in part due to poorly coordinated care transitions. Current hospital-to-home transitional care programs lack a focus on the integrated social, medical, and mental health needs of these patients. The Thrive clinical pathway provides transitional care support for patients insured by Medicaid with multiple chronic conditions by focusing on posthospitalization medical concerns and the social determinants of health. This study seeks to evaluate an adapted version of Thrive that also meets the needs of patients with co-occurring SMI discharged from a nonpsychiatric hospitalization. Objective: This study aimed to (1) engage staff and community advisors in participatory implementation processes to adapt the Thrive clinical pathway for all Medicaid-insured patients, including those with SMI; (2) examine utilization outcomes (ie, Thrive referral, readmission, emergency department [ED], primary, and specialty care visits) for Medicaid-insured individuals with and without SMI who receive Thrive compared with usual care; and (3) evaluate the acceptability, appropriateness, feasibility, and cost-benefit of an adapted Thrive clinical pathway that is tailored for Medicaid-insured patients with co-occurring SMI. Methods: This study will use a prospective, type I hybrid effectiveness-implementation, stepped-wedge, cluster randomized controlled trial design. We will randomize the initiation of Thrive referrals at the unit level. Data collection will occur over 24 months. Inclusion criteria for Thrive referral include individuals who (1) are Medicaid insured, dually enrolled in Medicaid and Medicare, or Medicaid eligible; (2) reside in Philadelphia; (3) are admitted for a medical diagnosis for over 24 hours at the study hospital; (4) are planned for discharge to home; (5) agree to receive home care services; and (6) are aged ≥18 years. Primary analyses will use a mixed-effects negative binomial regression model to evaluate readmission and ED utilization, comparing those with and without SMI who receive Thrive to those with and without SMI who receive usual care. Using a convergent parallel mixed methods design, analyses will be conducted simultaneously for the survey and interview data of patients, clinicians, and health care system leaders. The cost of Thrive will be calculated from budget monitoring data for the research budget, the cost of staff time, and average Medicaid facility fee payments. Results: This research project was funded in October 2023. Data collection will occur from April 2024 through December 2025. Results are anticipated to be published in 2025-2027. Conclusions: We anticipate that patients with and without co-occurring SMI will benefit from the adapted Thrive clinical pathway. We also anticipate the adapted version of Thrive to be deemed feasible, acceptable, and appropriate by patients, clinicians, and health system leaders. Trial Registration: ClinicalTrials.gov NCT06203509; https://clinicaltrials.gov/ct2/show/NCT06203509 International Registered Report Identifier (IRRID): DERR1-10.2196/64575